Drug Profile
Anti neural cell adhesion molecule L1 antibodies companion diagnostic - Elthera
Latest Information Update: 12 Oct 2023
Price :
$50
*
At a glance
- Originator Elthera
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Ovarian cancer; Pancreatic cancer
Most Recent Events
- 12 Oct 2023 Discontinued - Preclinical for Ovarian cancer (Diagnosis) in Switzerland (unspecified route) (Elthera pipeline, October 2023)
- 12 Oct 2023 Discontinued - Preclinical for Pancreatic cancer (Diagnosis) in Switzerland (unspecified route) (Elthera pipeline, October 2023)
- 28 Jul 2020 No recent reports of development identified for preclinical development in Ovarian-cancer(Diagnosis) in Switzerland